![Norman Eansor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norman Eansor
Chairman at
MARKER THERAPEUTICS, INC.
Net worth: 5 800 $ as of 31/05/2026
Profile
Norman David Eansor is currently Chairman at Marker Therapeutics, Inc. since 2022, Director at B-MoGen Biotechnologies, Inc., and President at Cyvek, Inc. Former positions include President-Bioproducts Business Unit at Cambrex Corp.
in 2005, President-Protein Sciences Segment at Bio-Techne Corp.
from 2018 to 2022, Vice President-Pharmaceutical Operations at R.P.
Scherer Corp., President-Bioscience Division at Thermo Fisher Scientific, Inc. from 2010 to 2013, Vice President-Operations at Cardinal Health Corp.
in 2000, and Senior Vice President-Development & MD at Novus Biologicals LLC from 2013 to 2015.
Education includes undergraduate studies at the University of Western Ontario and an MBA from the University of Windsor.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2026 | 3,694 ( 0.02% ) | 5 800 $ | 31/05/2026 |
Norman Eansor active positions
| Companies | Position | Start |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chairman | 24/05/2022 |
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Director/Board Member | - |
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology Engages in the development of a novel, platform technology for measuring analytes in biological samples | President | - |
Former positions of Norman Eansor
| Companies | Position | End |
|---|---|---|
| BIO-TECHNE CORPORATION | Corporate Officer/Principal | 03/01/2022 |
Novus Biologicals LLC
 Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Develops and markets antibodies for scientific researchers | Corporate Officer/Principal | 01/01/2015 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01/01/2013 |
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Cardinal Health Corp.
 Cardinal Health Corp. Medical DistributorsDistribution Services Manufactures and distributes hospital equipment | Chief Operating Officer | 01/01/2000 |
Training of Norman Eansor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
R.P. Scherer Corp.
 R.P. Scherer Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral drug delivery systems | Health Technology |
Bio-Techne Corp.
 Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology Engages in the development of a novel, platform technology for measuring analytes in biological samples | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Windsor
 University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Novus Biologicals LLC
Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Develops and markets antibodies for scientific researchers | Health Technology |
Cardinal Health Corp.
Cardinal Health Corp. Medical DistributorsDistribution Services Manufactures and distributes hospital equipment | Distribution Services |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Health Technology |
- Stock Market
- Insiders
- Norman Eansor
